HRTS is the worlds first ETF investing in GLP-1, addressing obesity and cardiometabolic diseases temaetfs.com Like Comment To view or add a comment, sign in 6,831 followers View Profile Follow More from this author Tema Trends: Powering Made in America Tema ETFs 1y Tema S&P 500 Historical Weight ETF DSPY Tema ETFs 1y Tariffs & Reshoring Tema ETFs 1y Explore content categories Career Productivity Finance Soft Skills & Emotional Intelligence Project Management Education Technology Leadership Ecommerce User Experience
In a 12-week clinical trial, participants lost weight and saw a reduction in waist/hips measurements
We already have one thats on the market, tirzepatide (Mounjaro), which is activating both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, and at least in terms of weight loss, appears to be somewhat more effective than semaglutide (Ozempic), says Professor Cummings
Without enough B12, the adrenal glands, which produce stress hormones like cortisol and adrenaline, can become fatigued
